1. Home
  2. SFNC vs IDYA Comparison

SFNC vs IDYA Comparison

Compare SFNC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFNC
  • IDYA
  • Stock Information
  • Founded
  • SFNC 1903
  • IDYA 2015
  • Country
  • SFNC United States
  • IDYA United States
  • Employees
  • SFNC N/A
  • IDYA N/A
  • Industry
  • SFNC Major Banks
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFNC Finance
  • IDYA Health Care
  • Exchange
  • SFNC Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • SFNC 2.2B
  • IDYA 1.9B
  • IPO Year
  • SFNC N/A
  • IDYA 2019
  • Fundamental
  • Price
  • SFNC $20.01
  • IDYA $22.69
  • Analyst Decision
  • SFNC Hold
  • IDYA Buy
  • Analyst Count
  • SFNC 3
  • IDYA 12
  • Target Price
  • SFNC $22.00
  • IDYA $50.82
  • AVG Volume (30 Days)
  • SFNC 756.1K
  • IDYA 1.0M
  • Earning Date
  • SFNC 07-17-2025
  • IDYA 08-05-2025
  • Dividend Yield
  • SFNC 4.21%
  • IDYA N/A
  • EPS Growth
  • SFNC N/A
  • IDYA N/A
  • EPS
  • SFNC 1.16
  • IDYA N/A
  • Revenue
  • SFNC $726,747,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • SFNC $22.95
  • IDYA $101.20
  • Revenue Next Year
  • SFNC $6.32
  • IDYA $286.70
  • P/E Ratio
  • SFNC $17.40
  • IDYA N/A
  • Revenue Growth
  • SFNC N/A
  • IDYA N/A
  • 52 Week Low
  • SFNC $17.20
  • IDYA $13.45
  • 52 Week High
  • SFNC $25.95
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • SFNC 61.11
  • IDYA 59.61
  • Support Level
  • SFNC $19.82
  • IDYA $20.99
  • Resistance Level
  • SFNC $20.31
  • IDYA $23.06
  • Average True Range (ATR)
  • SFNC 0.44
  • IDYA 0.94
  • MACD
  • SFNC 0.13
  • IDYA 0.01
  • Stochastic Oscillator
  • SFNC 78.88
  • IDYA 85.55

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: